OPIANT PHARMACEUTICALS INC's ticker is OPNT and the CUSIP is 683750103. A total of 33 filers reported holding OPIANT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $4,000 | -33.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,000 | -40.0% | 300 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $10,000 | +25.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $8,000 | +100.0% | 300 | 0.0% | 0.00% | +100.0% |
| Q2 2021 | $4,000 | +33.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $3,000 | +50.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | -33.3% | 300 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -25.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $4,000 | -20.0% | 300 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $5,000 | +25.0% | 300 | 0.0% | 0.00% | +100.0% |
| Q2 2019 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | 0.0% | 300 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 80,000 | $850,000 | 0.77% |
| PERRITT CAPITAL MANAGEMENT INC | 32,000 | $340,000 | 0.18% |
| Newbridge Financial Services Group, Inc. | 5,300 | $56,000 | 0.04% |
| Mesirow Financial Investment Management, Inc. | 753 | $8,000 | 0.02% |
| Marquette Asset Management, LLC | 7,941 | $84,000 | 0.02% |
| Renaissance Technologies | 222,815 | $2,366,000 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 59,831 | $635,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 10,400 | $110,000 | 0.00% |
| American Research & Management Co. | 300 | $3,000 | 0.00% |
| Certified Advisory Corp | 500 | $5,000 | 0.00% |